logo

VCEL

Vericel·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

VCEL fundamentals

Vericel (VCEL) released its earnings on Nov 6, 2025: revenue was 67.50M (YoY +16.56%), beat estimates; EPS was 0.1 (YoY +600.00%), beat estimates.
Revenue / YoY
67.50M
+16.56%
EPS / YoY
0.1
+600.00%
Report date
Nov 6, 2025
VCEL Earnings Call Summary for Q3,2025
  • MACI Dominance: Q3 revenue up 25% YoY to $55.7M, driven by 800+ trained surgeons and MACI Arthro adoption. Q4 guidance $82-84M, 2025 full year +20%.
  • Profit Surge: Adjusted EBITDA $17M (25% margin), free cash flow $20M. 2029 targets: 75%+ gross margin, 35%+ EBITDA.
  • Growth Catalysts: MACI Ankle study to begin Q4, U.K. launch 2027, and 25 new sales reps on track for Q4 completion.
  • Burn Care Volatility: NexoBrid Q3 high, but BARDA contract uncertain. Epicel Q4 expected stable.
EPS
Revenue

Revenue & Expenses

VCEL has released its 2025 Q3 earnings report, with revenue of 67.50M, reflecting a YoY change of 16.58%, and net profit of 5.07M, showing a YoY change of 663.15%. The Sankey diagram below clearly presents VCEL's revenue sources and cost distribution.

Key Indicators

Vericel (VCEL) key financial stats and ratios, covering profitability, financial health, and leverage.
Vericel (VCEL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Vericel (VCEL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Vericel (VCEL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Vericel (VCEL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Vericel (VCEL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield